Purpose Advances in minimally invasive therapies and novel targeted chemotherapeutics
have provided a breadth of options for the management of renal masses. Management of …

Purpose: We present a comprehensive resource that summarizes contemporary advances
relevant to the clinical management of renal angiomyolipoma. Materials and Methods: A …

Angiomyolipomas (AMLs) are the most common benign renal neoplasm and are often
discovered incidentally. Due to both an increase in the use of imaging, as well as advances …

OBJECTIVES: To evaluate the changing management of sporadic renal angiomyolipoma
and renal angiomyolipoma associated with the tuberous sclerosis complex (TSC) during the …

Background This study was performed to evaluate the impact of baseline characteristics and
treatment methods on the outcome of sporadic renal angiomyolipoma (AML). Methods This …

OBJECTIVES: Angiomyolipoma is a benign renal tumor that has a propensity to grow over
time and may cause local complications. Given the benign nature of these lesions, renal …

Purpose: We review our single center experience in the management of renal
angiomyolipoma (AML) in patients who were treated with active surveillance (AS) or …

Angiomyolipoma is the most common benign solid renal neoplasm observed in clinical
practice. Once thought to be a hamartoma and almost always diagnosed by the imaged …

PURPOSE: Angiomyolipomas classically present radiographically as fat containing lesions
but some fail to demonstrate fat content. Histologically confirmed angiomyolipomas …

BACKGROUND: The treatment for and long-term outcome of renal angiomyolipoma (AML)
at high-risk for bleeding has not been determined. OBJECTIVE: To evaluate the …